Located in the biotechnology hub of Cambridge, Massachusetts, our corporate headquarters is base camp for the leadership team, and supports functions such as business development, commercialization, communications, policy and advocacy, and investor relations.
160 Second Street, Floor 3 Cambridge, MA 02142
Phone: (617) 830-3031
Email: info@vbivaccines.com
Our research and development operation in Ottawa spans approximately 5,400 square feet of office and laboratory space. Here, we perform discovery and preclinical stage vaccine research, including target validation, vaccine formulation, and process development.
310 Hunt Club Road East,
Suite 201
Ottawa, Ontario K1V 1C1
Phone: (613) 749-4200
Our fully-owned and integrated GMP (Good Manufacturing Practice) manufacturing facility in Rehovot, Israel produces, validates, and releases our prophylactic 3-antigen HBV vaccine candidate at commercial scale, as well as the clinical material for VBI-2601, our HBV immunotherapeutic candidate.
Gad Feinstein Rd.
P.O. Box 580
Rehovot, Israel 7610303
Phone: +972-8-948-0625
General Inquiries:
Investor or Media Inquiries:
Partnership Inquiries:
